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Abstract
Mapping distribution of lymphatic filariasis (LF) is a prerequisite for planning national elimination
programmes. Results from a nation wide mapping survey for lymphatic filariasis (LF) in Malawi are
presented. Thirty-five villages were sampled from 23 districts excluding three districts (Karonga,
Chikwawa and Nsanje) that had already been mapped and Likoma, an Island, where access was not
possible in the time frame of the survey. Antigenaemia prevalence [based on
immunochromatographic card tests (ICT)] ranged from 0% to 35.9%. Villages from the western
side of the country and distant from the lake tended to be of lower prevalence. The exception was
a village in Mchinji district on the Malawi-Zambia border where a prevalence of 18.2% was found.
In contrast villages from lake shore districts [Salima, Mangochi, Balaka and Ntcheu (Bwanje valley)]
and Phalombe had prevalences of over 20%.
A national map is developed which incorporates data from surveys in Karonga, Chikwawa and
Nsanje districts, carried out in 2000. There is a marked decline in prevalence with increasing
altitude. Further analysis revealed a strong negative correlation (R2 = 0.7 p < 0.001) between
altitude and prevalence. These results suggest that the lake shore, Phalombe plain and the lower
Shire valley will be priority areas for the Malawi LF elimination programme. Implications of these
findings as regards implementing a national LF elimination programme in Malawi are discussed.
Background
Lymphatic filariasis (LF) has been identified as a major
public health problem and is endemic in over 80 coun-
tries. It is currently estimated that up to 120 million peo-
ple are infected with Wuchereria bancrofti in about 83
endemic countries [1]. Of these, it is estimated 40 million
people have evidence of chronic manifestations such as
hydrocele and lymphoedema/elephantiasis. In addition
the affected individuals suffer repeated episodes of ade-
nolymphangitis ('acute attacks') which result in marked
loss in their economic productivity [2]. Improved thera-
pies and diagnostic methods have led to the realisation
that it should be possible to interrupt transmission and
eliminate LF by repeated, annual cycles of mass drug
administration (MDA), with single dose combination reg-
imens [3]. Thus, in 1997 the World Health Assembly
passed a resolution calling for strengthening of activities
leading to the elimination of LF as a "public health prob-
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lem [4]." This resulted in the initiation of the now well-
established Global Program to Eliminate Lymphatic
Filariasis (GPELF) in 2000.
Malawi has two previously known LF foci: one in the
southern part (Shire valley) and the other in the northern
region along the Songwe river which forms its border with
Tanzania [5,6]. However there had been no detailed com-
munity based surveys for LF in Malawi apart from one in
the northern focus which was conducted in 1960. This
survey, based on microscopic examination (for microfila-
rae) of thick bloodsmears which were made from samples
collected at night, showed a high prevalence of microfila-
raemia amongst adults (40%) and suggested that human
infection with W. bancrofti was confined to communities
in close proximity to the Songwe River [7].
More recently, surveys in these two foci have reported
high antigenaemia prevalence based on immunochroma-
tographic (ICT) card tests that approached 80% in some
of the sampled villages [8,9]. There was also a higher than
expected prevalence of LF associated disease in both areas
(4% lymphoedema and up to 18% hydrocele). In addi-
tion, the survey in Karonga established that W. bancrofti
infection is more wide spread than previously recognised,
whereas in the lower Shire valley a markedly higher anti-
genaemia prevalence (55%) was found amongst children
(aged 1–9 years) than what has been reported in any of
the published literature.
Towards the end of 2003 we completed a nation-wide
mapping exercise using ICT cards. The objective was to
obtain data on the geographical distribution of LF in the
remaining districts in Malawi as a prerequisite to initiating
national LF elimination activities. This paper presents
findings from a 2003 survey and incorporates data from
recent surveys in the two known foci that have already
appeared in the scientific literature to produce, for the first
time, a complete map of the distribution of LF infection
(based on adult worm antigenaemia) in Malawi. The
implications of this distribution for LF control pro-
gramme planning and eventual implementation are dis-
cussed.
Methods
Malawi is administratively divided into northern, central
and southern regions. These are further divided into 28
districts. Two new districts (Neno – parent district –
Mwanza and Likoma Island – parent district – Nkhata-
Bay) were formed after this survey had already been
planned and thus were mapped within there parent dis-
tricts. In addition, access to Likoma, an Island District,
was not possible in the time frame of this survey. LF prev-
alence data were available for three districts; Karonga Dis-
trict in the northern region, Chikwawa and Nsanje
Districts in the southern region. The latest survey did not
cover these districts. In the remaining districts we aimed
to sample a random selection of villages for antigen test-
ing. A database of villages by district was made available
via the WHO's HealthMapper software. A programme
incorporated in the software was used to provide a ran-
dom sample of villages to be surveyed. The selected vil-
lages had a 50 km buffer zone as recommended by the
WHO's rapid assessment for the geographical distribution
of lymphatic filariasis (RAGFIL) method [10]. Three addi-
tional villages were chosen in the field from inhabited
areas from where the database did not contain any vil-
lages. The testing protocol adopted followed recommen-
dations of the RAGFIL method that is based on Lot
Quality Sampling (LQAS) scheme [11]. Briefly, if at least
10 (20%) of the first 50 individuals (aged >15 years)
tested were positive testing could be stopped; otherwise
up to 100 individuals were to be tested per sampling point
[11]. However since many villages are sparsely populated
an adjacent village to the randomly selected one were also
invited to participate in order to achieve the required sam-
ple size. Hence random selection of subjects was not fea-
sible in most villages. Before testing could be carried out a
meeting with village members was held and the objectives
of the survey were explained in the local language. Each
consenting individual provided demographic data (age
and sex) and a finger prick blood sample. The whole
blood obtained was immediately applied onto the ICT
(Binax Inc., Portland, ME) card and read within ten min-
utes according to the manufacturer's instructions. If two
lines appeared in the viewing window that particular indi-
vidual was regarded as positive for LF [12]. Individuals
found positive were treated on the spot with albendazole
(400 mg) and ivermectin (200 μg/kg body weight). All
sampled villages had geo-coordinates determined by a
portable Geographical Positioning System (GPS-Garmin
eTrex®) machine.
Ethics
The survey received ethical clearance from the Malawi
Ministry of Health Sciences Research Committee (HSRC)
and from the Liverpool School of Tropical Medicine Eth-
ics Committee. Individual consent was obtained from
each participant or (if they were aged <16) from one of
their parents or a guardian.
Data Management
Data were entered into the computer using EPINFO 2000
(CDC, Atlanta) software. The data were subsequently
exported into STATA version 7 (Stata Corporation, Col-
lege Station, TX) for descriptive statistical analyses. In
order to investigate the relationship between prevalence
and altitude, log transformation of the prevalence data
was carried out using the formula log10 (x + 1). Village
geographical coordinate data were used to produce a mapFilaria Journal 2007, 6:12 http://www.filariajournal.com/content/6/1/12
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showing the spatial distribution of LF infection using the
WHO's HealthMapper software.
Results
A total of 35 data points were sampled. Of these three
were chosen in the field in inhabited areas where there
were no villages on the Healthmapper database. A total of
2913 individuals were examined. The age and sex distri-
bution of the survey participants is shown in Figure 1.
There was a female excess (64%) amongst the study par-
ticipants (more marked in the 20–24 age bracket). Overall
there were 269 (9.2%) individuals positive for circulating
filarial antigen (CFA) based on ICT results. Significantly
more males than females tested positive (11.0% vs 8.2%
p = 0.01). Figure 2 shows the proportion of those positive
for CFA by age and sex. Amongst the males, those positive,
tended to be older (student t test p = 0.08). This relation-
ship was not observed in their female counterparts.
Survey prevalence data by district and village are pre-
sented in Table 1. This ranged from 0% to 35.9%. The spa-
tial distribution of the sampled villages with their
prevalence category are shown in Figure 3. In general vil-
lages in the western side of the country registered a CFA
prevalence of less than 10%. This is with the exception of
Mzenga Village in Mchinji District along the Malawi-Zam-
bia border where a prevalence of 18.2% was found. Prev-
alence of over 20% was observed from villages in Salima
and Mangochi Districts along the southern shore of Lake
Malawi. Also in Ntcheu district (Bwanje Valley), Balaka
district near Lake Malombe and finally in Phalombe dis-
trict along the shores of Lake Chilwa. The highest preva-
lence (35.9%) was recorded at Kalembo village in Balaka
district in southern Malawi.
Prevalence data from the 2000 surveys are summarised in
Table 2. The geographical distribution of data points sam-
pled (ICT) in Malawi (except two villages in Nsanje Dis-
trict where it was not possible to obtain geographical
coordinates) showing prevalence in relation to altitude is
presented in Figure 4. Figure 5(a) shows a scatter plot of
antigen prevalence by altitude. There is notable decline in
prevalence with increasing altitude and further statistical
analyses on log transformed prevalence data [Figure 5(b)]
have shown a significant negative correlation between
altitude and prevalence (R2 = 0.7 p < 0.001).
Discussion
The present survey, in the remaining unmapped districts
in Malawi, has shown that infection with W. bancrofti as
determined by antigenaemia prevalence is more wide-
spread than previously appreciated. The female excess
observed amongst our survey population probably
reflects the fact that males are often out in the field during
the day thus not available for testing. The implication of
this being that the prevalence we found in some of our
sampled villages is likely to be an under-estimate of the
true prevalence. This is due to the fact that in most com-
munities significantly more males tend to carry the infec-
tion as has been observed in this survey and in other
surveys from Malawi and elsewhere in Africa [9,13].
In all districts, except Chitipa in the north, there was at
least one individual who was positive on ICT. The low
prevalence found in villages from the western side of
Malawi could be explained by the fact that these areas are
dry, of relatively higher altitude and thus not ideal for
extensive mosquito breeding. The 18.2% prevalence
observed at Mzenga Village in Mchinji along the Zambia
border is intriguing. This is particularly so as there have
been no anecdotal reports of LF disease from either the
Malawi or Zambia side of the border in this area. Of note
is that this village is in close proximity to a perennial
stream that sustains a reasonable amount of irrigated
The proportion of males and females positive for CFA by age Figure 2
The proportion of males and females positive for CFA by 
age.
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The age and sex distribution of survey participants Figure 1
The age and sex distribution of survey participants.
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onion farming. Whether this setting is conducive for sup-
porting extensive mosquito breeding and thus driving W.
bancrofti  infection as has been observed in Northern
Malawi and Ghana will need further investigation [14].
Ideally this should be coupled with human night blood
examination for microfilariae.
It is also interesting to note that some villages from dis-
tricts (Rumphi, Nkhata-Bay and Nkhotakota) along the
lake shore had prevalence of less than 10%. A possible
explanation could be due to the fact that these districts are
mountainous and thus well drained consequently limit-
ing potential mosquito breeding sites.
The relatively high prevalence found in Salima, Ntcheu
(Bwanje Valley), Balaka, Mangochi and Phalombe was
unexpected. However there have been isolated unpub-
lished reports of cases with chronic manifestation of LF
(hydrocele and elephantiasis) in these areas. It is worth
noting that the ecological conditions in these districts are
ideal for supporting large potential LF vector populations.
Incorporating data from 2000 surveys clearly shows that
the priority areas for LF control activities in Malawi will be
the lakeshore districts, Phalombe plain and the Lower
Shire Valley.
The decline in LF prevalence with increasing altitude has
also been reported from other settings in Africa [15]. This
is believed to be due to the influence of altitude on tem-
perature which is known to be critical for survival of the
vector and development of the parasite within the vector
[16].
These findings have important implications for initiating
the "Malawi LF Elimination Programme". First, following
WHO's recommendation that all implementation units
Table 1: ICT antigen prevalence data from the nation wide survey conducted in 2003
District Village Number tested Number positive Prevalence Latitude Longitude
Balaka Kalembo 53 19 35.8 14.84500 35.16900
Blantyre Masanjala Lilangwe 77 5 6.5 15.54490 35.02184
Chiradzulu Mbalame 81 6 7.4 15.70000 35.10000
Chitipa Chisenga 85 0 0 9.97500 33.38977
Chitipa Siyombwe 77 0 0 9.68441 33.24764
Dedza Kamenyagwaza 64 5 7.8 14.40750 34.98750
Dowa Chimangamsasa 72 4 5.6 13.70964 33.99795
Kasungu Kadyaka 65 0 0 13.07633 33.48360
Kasungu Kaluluma 105 3 2.9 12.58077 33.51870
Lilongwe Mwenda 1 T/A Chadza 84 6 7.1 14.14074 33.78825
Machinga Phuteya 70 3 4.3 15.19000 35.09887
Mangochi Chilawe 92 9 9.8 13.80000 35.10300
Mangochi Chiponde 90 12 13.3 14.38300 35.10000
Mangochi Mtuwa 82 21 25.6 14.68400 35.55100
Mchinji Chalaswa 98 4 4.1 14.11689 33.32919
Mchinji Mzenga 99 18 18.2 13.60427 32.73460
Mulanje Gawani 78 6 7.7 15.98100 35.78300
Mulanje Mbewa 69 13 18.8 15.99970 35.48611
Mwanza Chapita A 64 3 4.7 15.63022 34.59139
Mzimba Milingo-Jere 101 0 0 12.20374 33.33340
Mzimba Kambombo 102 2 1.9 11.17551 33.52649
Nkhata-Bay Kalumpha 104 7 6.7 12.08733 34.05695
Nkhata-Bay Mizimu 103 8 7.8 11.55820 34.18150
Nkhotakota Mowe 122 11 9 12.55496 34.13366
Nkhotakota Tandwe 81 3 3.7 13.02981 34.26246
Ntcheu Gwaza 92 26 28.3 14.52800 34.68000
Ntcheu Nkonde-1 66 6 9.1 14.98570 34.82825
Ntchisi Kalulu 99 3 3 13.33129 33.74804
Phalombe Maguda 78 19 24.4 15.51774 35.78996
Rumphi Bongololo 72 1 1.4 10.81276 33.52233
Rumphi Mhango 82 8 9.8 10.81000 33.52379
Salima Chipoka-Nkwizi 73 16 21.9 14.03676 34.50614
Salima Kasonda 78 13 16.7 13.59828 34.29268
Thyolo Nkaombe 95 6 6.3 15.99271 35.04998
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with a prevalence on ICT of over 1% be considered
endemic and thus treated, the Malawi programme would
involve 27 districts with a target population of over ten
million. The population affected is far greater than ever
envisaged. Secondly, both the northern (Karonga) and
Southern foci (the Lower Shire Valley) share international
borders which are largely porous. This calls for innovative
approaches in carrying out control activities as they have
to be synchronised with those in neighbouring countries.
Thirdly, in some districts (Phalombe, Mulanje, Thyolo,
Chikwawa and Mwanza) where LF is co-endemic with
onchocercisasis the two programmes will need to be
merged. Fourthly, the LF programme will need to estab-
lish links with other programmes that are delivering com-
munity based interventions such as the ministry of
education's deworming and feeding programme and the
expanded bed net distribution under the malaria control
programme.
Table 2: ICT antigen prevalence data from surveys conducted in 2000
District Village Number tested Number positive Prevalence Latitude Longitude
Karonga Mwenitete 42 20 47.6 9.71257 33.92973
Karonga Mwakyusa 91 44 48.7 9.69795 33.89313
Karonga Mwenepela 102 59 57.8 9.67193 33.8252
Karonga Kashata 50 22 44 9.73315 33.88652
Karonga Mwamsaku 50 22 44 9.8092 33.86483
Karonga Mwambetania 50 29 58 9.86747 33.86892
Karonga Kafikisila 51 23 45.1 9.91213 33.93105
Karonga Mwenitete-mpata 50 24 48 9.94957 33.82237
Karonga Ngosi 50 15 30 10.01228 33.94907
Karonga Mwakabanga 50 15 30 10.14422 34.01782
Karonga Kanyuka 51 14 27.5 10.30768 34.12692
Karonga Bonje 50 28 56 10.49027 34.17098
Nsanje Chazuka 148 60 40.5 16.84261 35.25259
Nsanje Nchacha18 148 86 58.1 16.63617 35.17126
Nsanje Gamba 84 56 66.7 16.5811 35.14076
Chikwawa Nchingula 128 76 59.4 15.99828 34.48297
Chikwawa Zilipaine 129 96 74.4 16.07998 34.88262
Chikwawa Mbande 108 76 70.4 16.16167 34.79332
Chikwawa Pende 116 79 68.1 16.04362 34.72428
Chikwawa Belo 196 155 79.1 16.02093 34.8162
Chikwawa Mfunde 87 29 33.3 16.19929 35.01652
Chikwawa Kasokeza 60 34 56.7 16.11213 34.92532
Chikwawa Khumbulani 59 9 15.3 15.99232 34.8791
Chikwawa Muyaya 78 21 26.9 16.04667 34.90783
Map of Malawi showing the prevalence levels recorded in the  2003 survey Figure 3
Map of Malawi showing the prevalence levels recorded in the 
2003 survey.
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